Table 1.
Cases (n=2766) | Controls (n=2377) | ||
---|---|---|---|
Age, years | 35 (28–45) | 32 (26–42) | |
Sex | |||
Male | 1804 (65·2%) | 1626 (68·4%) | |
Female | 962 (34·8%) | 751 (31·6%) | |
High risk of COVID-19 exposure at workplace | 56 (2·0%) | 60 (2·5%) | |
Duration between the two vaccine doses among vaccinated participants, days | 33 (29–50; n=109) | 31 (28–45; n=202) | |
Mild COVID-19 symptoms | 2679 (96·5%) | NA | |
Oxygen supplementation | 89 (3·2%) | NA | |
Admission to the intensive care unit | 26 (0·9%) | NA | |
Ventilatory support | 7 (0·3%) | NA | |
Death | 16 (0·6%) | NA |
Data are median (IQR) or n (%). NA=not applicable.